Page last updated: 2024-08-23

bromocriptine and pramipexole

bromocriptine has been researched along with pramipexole in 37 studies

Research

Studies (37)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's11 (29.73)18.2507
2000's19 (51.35)29.6817
2010's6 (16.22)24.3611
2020's1 (2.70)2.80

Authors

AuthorsStudies
Griffon, N; Lévesque, D; Pilon, C; Sautel, F; Schwartz, JC; Sokoloff, P1
Andricopulo, AD; Moda, TL; Montanari, CA1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hoffmann, WE; Hyslop, DK; Piercey, MF; Smith, MW1
Fici, GJ; Sethy, VH; VonVoigtlander, PF; Wu, H1
Hall, ED; Oostveen, JA; Sethy, VH; Wu, H1
Kitamura, Y; Kohno, Y; Nakazawa, M; Nomura, Y1
Wienkers, LC; Wynalda, MA1
Guttman, M1
Kakimura, JI; Kitamura, Y; Kohno, Y; Kosaka, T; Matsuoka, Y; Nomura, Y; Taniguchi, T1
Factor, SA1
Weiner, WJ1
Montastruc, JL; Rascol, O; Senard, JM1
Clarke C, E; Clarke J, A; Speller J, M1
Brannan, T; Prikhojan, A; Yahr, MD1
Sternon, J; Supiot, F; Zegers de Beyl, D1
Jankovic, J; Le, WD1
Diroma, C; Fraddosio, A; Iliceto, G; Lamberti, S; Moramarco, A; Palagano, G; Zenzola, A1
Gekht, AB1
Blackman, JA; Buck, ML; Conaway, MR; Patrick, PD1
Bankowski, BJ; Zacur, HA1
Hasegawa, K; Kowa, H; Kuno, S; Mizuno, Y; Origasa, H; Yamamoto, M; Yanagisawa, N1
Lang, AE; Razmy, A; Shapiro, CM1
Grosset, D; Grosset, K; Macphee, G; Needleman, F1
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C1
Daida, H; Hatano, T; Hattori, N; Iwama, Y; Komine-Kobayashi, M; Mizuno, Y; Mochizuki, H; Nakayama, T; Sakai, M; Urabe, T; Yamashiro, K1
Akaike, A; Izumi, Y; Kume, T; Niidome, T; Oda, T; Takada-Takatori, Y1
Doi, K; Isono, T; Kawamura, T; Kitagawa, N; Kuno, S; Masaki, M; Mizuta, E; Oeda, T; Sawada, H; Taniguchi, S; Yaku, H; Yamamoto, K; Yutani, C1
Andersohn, F; Garbe, E1
Audebert, C; Blin, O; Eusebio, A; Jouve, E; Micallef, J; Rey, M; Rouby, F; Tardieu, S1
Fujioka, S; Iwamoto, K; Kawamura, M; Nakajima, M; Ohno, H1
Bottasini, V; Clemens, S; Ferini-Strambi, L; Ferri, R; Giarolli, L; Manconi, M; Zucconi, M1
Hashida, H; Hattori, N; Iijima, M; Kano, O; Kubo, S; Matsumura, M; Murakami, H; Nanri, K; Okuma, Y; Suzuki, M; Suzuki, Y; Tomimitsu, H; Utsumi, H1
Agúndez, JA; Alonso-Navarro, H; García-Martín, E; Jiménez-Jiménez, FJ1
Dieb, W; Durif, F; Hafidi, A; Ouachikh, O1
Ji, F; Jiang, R; Su, Z; Xue, R; Zhou, Y; Zhu, X; Zhuo, C1
Chen, F; Chen, X; Wen, S; Zhang, Q; Zhou, C1

Reviews

12 review(s) available for bromocriptine and pramipexole

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Dopamine agonists.
    The Medical clinics of North America, 1999, Volume: 83, Issue:2

    Topics: Apomorphine; Benzothiazoles; Bromocriptine; Dopamine Agonists; Humans; Indoles; Parkinson Disease; Pergolide; Pramipexole; Randomized Controlled Trials as Topic; Receptors, Dopamine; Thiazoles; Treatment Outcome

1999
The initial treatment of Parkinson's disease should begin with levodopa.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5

    Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Drug Therapy, Combination; Essential Tremor; Female; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine; Thiazoles; Time Factors

1999
Treatment of Parkinson's disease should begin with a dopamine agonist.
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:5

    Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Indoles; Levodopa; Lisuride; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D2; Thiazoles

1999
Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    The Cochrane database of systematic reviews, 2000, Issue:3

    Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Tolerance; Humans; Levodopa; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Thiazoles

2000
Are dopamine receptor agonists neuroprotective in Parkinson's disease?
    Drugs & aging, 2001, Volume: 18, Issue:6

    Topics: Animals; Antiparkinson Agents; Apomorphine; Benzothiazoles; Bromocriptine; Cell Culture Techniques; Clinical Trials as Topic; Dopamine Agonists; Humans; Indoles; Models, Animal; Neuroprotective Agents; Parkinson Disease; Pergolide; Pramipexole; Substantia Nigra; Thiazoles

2001
[Use of dopamine agonists in the treatment of Parkinson's disease].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2002, Volume: 102, Issue:9

    Topics: Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Controlled Clinical Trials as Topic; Dopamine Agonists; Ergolines; Humans; Indoles; Lisuride; Parkinson Disease; Pergolide; Piribedil; Placebos; Pramipexole; Serotonin Receptor Agonists; Thiazoles; Time Factors

2002
Dopamine agonist therapy for hyperprolactinemia.
    Clinical obstetrics and gynecology, 2003, Volume: 46, Issue:2

    Topics: Aminoquinolines; Benzothiazoles; Bromocriptine; Cabergoline; Clinical Trials as Topic; Dopamine Agonists; Ergolines; Ergoloid Mesylates; Female; Humans; Hyperprolactinemia; Indoles; Pergolide; Pramipexole; Thiazoles

2003
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
    Movement disorders : official journal of the Movement Disorder Society, 2005, Volume: 20, Issue:5

    Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone

2005
Anti-Parkinson's disease drugs and pharmacogenetic considerations.
    Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:7

    Topics: Aryl Hydrocarbon Hydroxylases; Benzothiazoles; Benztropine; Bromocriptine; Cabergoline; Catechols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Ergolines; Genetic Markers; Humans; Indans; Indoles; Levodopa; Lisuride; Nitriles; Parkinson Disease; Pergolide; Pharmacogenetics; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Selegiline

2013
Comparison for Efficacy and Tolerability among Ten Drugs for Treatment of Parkinson's Disease: A Network Meta-Analysis.
    Scientific reports, 2017, 04-04, Volume: 8

    Topics: Bromocriptine; Cluster Analysis; Dopamine Agonists; Drug Therapy, Combination; Humans; Indoles; Levodopa; Network Meta-Analysis; Parkinson Disease; Picolinic Acids; Pramipexole; Selegiline; Tetrahydronaphthalenes; Thiophenes

2017
Dopamine agonists versus levodopa monotherapy in early Parkinson's disease for the potential risks of motor complications: A network meta-analysis.
    European journal of pharmacology, 2023, Sep-05, Volume: 954

    Topics: Antiparkinson Agents; Bromocriptine; Dopamine Agonists; Dyskinesias; Humans; Levodopa; Network Meta-Analysis; Parkinson Disease; Pergolide; Pramipexole

2023

Trials

6 trial(s) available for bromocriptine and pramipexole

ArticleYear
Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.
    Neurology, 1997, Volume: 49, Issue:4

    Topics: Adult; Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Double-Blind Method; Female; Humans; Male; Middle Aged; Parkinson Disease; Placebos; Pramipexole; Quality of Life; Severity of Illness Index; Thiazoles; Treatment Outcome

1997
Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:10

    Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Demography; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Middle Aged; Parkinson Disease; Pramipexole; Prospective Studies; Quality of Life; Thiazoles; Time Factors; Treatment Outcome

2003
Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects.
    British journal of clinical pharmacology, 2009, Volume: 67, Issue:3

    Topics: Adolescent; Adult; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cross-Over Studies; Double-Blind Method; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Pramipexole; Sleep Wake Disorders; Treatment Outcome; Young Adult

2009
Overnight switching from ergot-derived dopamine agonists to pramipexole in patients with Parkinson's disease: an open preliminary trial in Japan.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2009, Volume: 16, Issue:6

    Topics: Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Ergolines; Humans; Japan; Outcome Assessment, Health Care; Parkinson Disease; Pergolide; Pramipexole; Severity of Illness Index; Time Factors; Treatment Outcome

2009
Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome.
    Neurology, 2011, Jul-12, Volume: 77, Issue:2

    Topics: Adult; Aged; Analysis of Variance; Benzothiazoles; Bromocriptine; Cross-Over Studies; Electromyography; Female; Humans; Leg; Male; Middle Aged; Movement; Pain Measurement; Polysomnography; Pramipexole; Prospective Studies; Receptors, Dopamine D2; Receptors, Dopamine D3; Restless Legs Syndrome; Single-Blind Method; Statistics, Nonparametric

2011
Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease.
    Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:3

    Topics: Aged; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Dyskinesia, Drug-Induced; Ergolines; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3

2013

Other Studies

19 other study(ies) available for bromocriptine and pramipexole

ArticleYear
A functional test identifies dopamine agonists selective for D3 versus D2 receptors.
    Neuroreport, 1995, Jan-26, Volume: 6, Issue:2

    Topics: Animals; CHO Cells; Cricetinae; Dopamine Agents; Humans; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3

1995
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists.
    European journal of pharmacology, 1996, Sep-19, Volume: 312, Issue:1

    Topics: Animals; Antiparkinson Agents; Benzothiazoles; Bromocriptine; CHO Cells; Cricetinae; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Substantia Nigra; Thiazoles

1996
D1 dopamine receptor activity of anti-parkinsonian drugs.
    Life sciences, 1997, Volume: 60, Issue:18

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Apomorphine; Benzazepines; Benzothiazoles; Bromocriptine; Cells, Cultured; Cerebellum; Clozapine; Cyclic AMP; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Pergolide; Pramipexole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Tetrahydronaphthalenes; Thiazoles

1997
Neuroprotective effects of the dopamine agonists pramipexole and bromocriptine in 3-acetylpyridine-treated rats.
    Brain research, 1997, Apr-18, Volume: 754, Issue:1-2

    Topics: Adenosine Triphosphate; Animals; Benzothiazoles; Body Temperature; Bromocriptine; Cerebellum; Cyclic GMP; Dopamine Agonists; Male; Motor Activity; Neurons; Neuroprotective Agents; Neurotoxins; Olivary Nucleus; Pramipexole; Pyridines; Rats; Rats, Wistar; Thiazoles

1997
Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice.
    Japanese journal of pharmacology, 1997, Volume: 74, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Azepines; Benzothiazoles; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Homovanillic Acid; In Vitro Techniques; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Neostriatum; Pramipexole; Synaptosomes; Thiazoles

1997
Assessment of potential interactions between dopamine receptor agonists and various human cytochrome P450 enzymes using a simple in vitro inhibition screen.
    Drug metabolism and disposition: the biological fate of chemicals, 1997, Volume: 25, Issue:10

    Topics: Benzothiazoles; Bromocriptine; Cytochrome P-450 Enzyme Inhibitors; Dopamine Agonists; Enzyme Inhibitors; Humans; Indoles; Pergolide; Pramipexole; Thiazoles

1997
Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells.
    Molecular pharmacology, 1998, Volume: 54, Issue:6

    Topics: 1-Methyl-4-phenylpyridinium; Antiparkinson Agents; Apoptosis; Azepines; Benzothiazoles; Bromocriptine; Bucladesine; Caspase 3; Caspases; Dopamine Agonists; Humans; Pramipexole; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53

1998
Comparative effects of repeated administration of dopamine agonists on circling behavior in rats.
    Journal of neural transmission (Vienna, Austria : 1996), 2000, Volume: 107, Issue:10

    Topics: Animals; Benzothiazoles; Brain; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Ergolines; Indoles; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pergolide; Pramipexole; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2; Thiazoles

2000
[Dopaminergic agonists in the treatment of Parkinson's disease].
    Revue medicale de Bruxelles, 2000, Volume: 21, Issue:6

    Topics: Aged; Antiparkinson Agents; Apomorphine; Benzothiazoles; Biological Availability; Bromocriptine; Catechols; Dopamine Agonists; Drug Combinations; Drug Hypersensitivity; Humans; Hypotension, Orthostatic; Indoles; Levodopa; Metabolic Clearance Rate; Nitriles; Parkinson Disease; Pergolide; Pramipexole; Selegiline; Thiazoles

2000
Efficacy and tolerability of dopamine agonists in a parkinsonian population.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:1

    Topics: Age of Onset; Aged; Aging; Benzothiazoles; Bromocriptine; Dopamine Agonists; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Drug Tolerance; Ergolines; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Lisuride; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome

2001
The use of dopamine enhancing medications with children in low response states following brain injury.
    Brain injury, 2003, Volume: 17, Issue:6

    Topics: Adolescent; Adult; Amantadine; Arousal; Awareness; Benzothiazoles; Brain Injuries; Bromocriptine; Child; Dopamine Agents; Dopamine Agonists; Female; Humans; Levodopa; Male; Methylphenidate; Neuropsychological Tests; Pramipexole; Retrospective Studies; Thiazoles; Treatment Outcome; Unconsciousness

2003
Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
    Archives of neurology, 2004, Volume: 61, Issue:1

    Topics: Aged; Benzothiazoles; Bromocriptine; Disorders of Excessive Somnolence; Dopamine Agonists; Dose-Response Relationship, Drug; Ergot Alkaloids; Female; Humans; Indoles; Male; Middle Aged; Parkinson Disease; Pergolide; Polysomnography; Pramipexole; Prospective Studies; Sleep; Thiazoles; Wakefulness

2004
Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table.
    Movement disorders : official journal of the Movement Disorder Society, 2004, Volume: 19, Issue:11

    Topics: Adult; Adverse Drug Reaction Reporting Systems; Antiparkinson Agents; Benzothiazoles; Bromocriptine; Cabergoline; Domperidone; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Ergot Alkaloids; Feasibility Studies; Female; Follow-Up Studies; Humans; Indoles; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Pramipexole; Therapeutic Equivalency; Thiazoles

2004
The frequency of cardiac valvular regurgitation in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2008, May-15, Volume: 23, Issue:7

    Topics: Aged; Aortic Valve Insufficiency; Azepines; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Prevalence

2008
Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.
    European journal of pharmacology, 2008, Nov-19, Volume: 598, Issue:1-3

    Topics: Animals; Azepines; Benzothiazoles; Blotting, Western; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergonovine; Ergot Alkaloids; Methylergonovine; Mitogen-Activated Protein Kinases; Neurites; PC12 Cells; Pramipexole; Rats; Receptors, Dopamine D2

2008
High risk factors for valvular heart disease from dopamine agonists in patients with Parkinson's disease.
    Journal of neural transmission (Vienna, Austria : 1996), 2009, Volume: 116, Issue:2

    Topics: Age Factors; Aged; Benzothiazoles; Bromocriptine; Cabergoline; Case-Control Studies; Dopamine Agonists; Echocardiography; Ergolines; Female; Heart Valve Diseases; Humans; Hypertension; Male; Parkinson Disease; Pergolide; Pramipexole; Risk Factors

2009
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Jan-15, Volume: 24, Issue:1

    Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Endomyocardial Fibrosis; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Pergolide; Pericarditis; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Tetrahydronaphthalenes; Thiophenes; United States

2009
Anterior ventral tegmental area dopaminergic neurons are not involved in the motivational effects of bromocriptine, pramipexole and cocaine in drug-free rats.
    Behavioural brain research, 2014, Apr-01, Volume: 262

    Topics: Animals; Benzothiazoles; Bromocriptine; Cocaine; Conditioning, Psychological; Dopamine Agonists; Dopaminergic Neurons; Male; Motivation; Motor Activity; Pramipexole; Rats; Rats, Sprague-Dawley; Ventral Tegmental Area

2014